ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 134 filers reported holding ITEOS THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $240,541 | +24.6% | 17,635 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $193,103 | 0.0% | 17,635 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $193,103 | -17.3% | 17,635 | +0.0% | 0.00% | -33.3% |
| Q2 2023 | $233,448 | +96766.4% | 17,632 | -0.2% | 0.00% | -25.0% |
| Q1 2023 | $241 | -30.3% | 17,672 | -0.3% | 0.00% | -42.9% |
| Q4 2022 | $346 | -99.9% | 17,730 | -30.4% | 0.01% | -41.7% |
| Q2 2021 | $654,000 | – | 25,485 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |